NEW YORK (GenomeWeb News) - Columbia University said yesterday that it has licensed a pathogen-detection technology called MassTag PCR to Indian contract research and testing organization Vimta Labs.

Vimta will use the technology to develop clinical diagnostic products for patients in India, the university's technology transfer arm, Columbia Science and Technology Ventures, said in a statement.

MassTags are small chemical compounds of different molecular weights that are added to nucleotide primer sequences by an ultraviolet photocleaver linker, the STV said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.